Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Cranio : the Journal of Craniomandibular Practice
|
October 18, 2014
Efficacy of treatment of insomnia in migraineurs with eszopiclone (Lunesta®) and its effect on total sleep time, headache frequency, and daytime functioning: A randomized, double-blind, placebo-controlled, parallel-group, pilot study
Egilius L H Spierings, Peter J McAllister, Tanya R Bilchik
Pain
|
October 31, 2006
Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A
Moshe Jakubowski, Peter J McAllister, Zahid H Bajwa, et al.
International Journal of General Medicine
|
March 4, 2015
Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety
Guy P Boudreau, Brian M Grosberg, Peter J McAllister, et al.
Journal of Rehabilitation Medicine
|
September 19, 2019
Effects on walking of simultaneous upper/lower limb abobotulinumtoxina injections in patients with stroke or brain injury with spastic hemiparesis
Peter J McAllister, Svetlana E Khatkova, Steven G Faux, et al.
Headache
|
May 13, 2017
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered<sup>®</sup> Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan
Stephen Silberstein, Paul K Winner, Peter J McAllister, et al.
Headache
|
October 31, 2014
A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study)
Roger K Cady, Peter J McAllister, Egilius L H Spierings, et al.
Headache
|
November 29, 2021
Timing and durability of response to erenumab in patients with episodic migraine
Peter J McAllister, Ira Turner, Uwe Reuter, et al.
Cephalalgia : an International Journal of Headache
|
December 10, 2019
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response
Jan Lewis Brandes, Hans-Christoph Diener, David Dolezil, et al.
The Lancet. Neurology
|
November 9, 2019
Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial
Peter J Goadsby, Soma Sahai-Srivastava, Eric J Kezirian, et al.
Science Advances
|
December 27, 2018
Ancient nuclear genomes enable repatriation of Indigenous human remains
Joanne L Wright, Sally Wasef, Tim H Heupink, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Cranio : the Journal of Craniomandibular Practice
|
October 18, 2014
Efficacy of treatment of insomnia in migraineurs with eszopiclone (Lunesta®) and its effect on total sleep time, headache frequency, and daytime functioning: A randomized, double-blind, placebo-controlled, parallel-group, pilot study
Egilius L H Spierings, Peter J McAllister, Tanya R Bilchik
Pain
|
October 31, 2006
Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A
Moshe Jakubowski, Peter J McAllister, Zahid H Bajwa, et al.
International Journal of General Medicine
|
March 4, 2015
Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety
Guy P Boudreau, Brian M Grosberg, Peter J McAllister, et al.
Journal of Rehabilitation Medicine
|
September 19, 2019
Effects on walking of simultaneous upper/lower limb abobotulinumtoxina injections in patients with stroke or brain injury with spastic hemiparesis
Peter J McAllister, Svetlana E Khatkova, Steven G Faux, et al.
Headache
|
May 13, 2017
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered<sup>®</sup> Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan
Stephen Silberstein, Paul K Winner, Peter J McAllister, et al.
Headache
|
October 31, 2014
A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study)
Roger K Cady, Peter J McAllister, Egilius L H Spierings, et al.
Headache
|
November 29, 2021
Timing and durability of response to erenumab in patients with episodic migraine
Peter J McAllister, Ira Turner, Uwe Reuter, et al.
Cephalalgia : an International Journal of Headache
|
December 10, 2019
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response
Jan Lewis Brandes, Hans-Christoph Diener, David Dolezil, et al.
The Lancet. Neurology
|
November 9, 2019
Safety and efficacy of sphenopalatine ganglion stimulation for chronic cluster headache: a double-blind, randomised controlled trial
Peter J Goadsby, Soma Sahai-Srivastava, Eric J Kezirian, et al.
Science Advances
|
December 27, 2018
Ancient nuclear genomes enable repatriation of Indigenous human remains
Joanne L Wright, Sally Wasef, Tim H Heupink, et al.
Page
of 2